|
Age (years; mean [range])
|
35.0 (21 to 56)
|
|
Sex (n; males/females)
|
2/41
|
|
Disease duration (years; mean [range])
|
8.5 (0.1 to 18)
|
|
SLEDAI (mean ± SD)
|
3.72 ± 3.84
|
|
Active (n = 9)a
|
9.55 ± 4.50
|
|
Inactive (n = 34)
|
2.17 ± 1.42
|
|
Cutaneous manifestation (n [%])
|
26 (60.5)
|
|
Arthritis (n [%])
|
27 (62.8)
|
|
Renal manifestation (n [%])
|
9 (20.9)
|
|
Cytopenia (n [%])
|
11 (25.6)
|
|
Serositis (n [%])
|
8 (18.6)
|
|
Prednisolone (n [%]; mean dosage [mg/day])
|
41 (95.3); 13.0
|
|
Hydroxychloroquine (n [%])
|
34 (79.1)
|
|
Azathioprine (n [%])
|
4 (9.3)
|
|
Cyclosporin (n [%])
|
1 (2.3)
|
|
Mizoribine (n [%])
|
4 (9.3)
|
|
Mycophenolate mofetil (n [%])
|
3 (7.0)
|
